Cargando…
Long–term Neurodevelopment outcomes to Prenatal Antipsychotic Medication Exposure: Systemic Review
INTRODUCTION: Peak incidence for many psychiatric disorders occurs in reproductive years. We don’t have FDA-approved drugs or clinical guidelines. The main cause of pharmacological suspension in pregnancy is the lack of knowledge of their effects on the product. Gathering information on this regard...
Autor principal: | González Campos, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434681/ http://dx.doi.org/10.1192/j.eurpsy.2023.1070 |
Ejemplares similares
-
Prenatal Exposure to PBDEs and Neurodevelopment
por: Herbstman, Julie B., et al.
Publicado: (2010) -
Prenatal Exposure to Phthalates and Neurodevelopment in the CHAMACOS Cohort
por: Hyland, Carly, et al.
Publicado: (2019) -
Neurodevelopment in school‐aged children after intrauterine exposure to antipsychotics
por: Schrijver, Lisanne, et al.
Publicado: (2022) -
The Role of Cannabinoidergic System in Prenatal Neurodevelopment
por: Naderi, Nima
Publicado: (2013) -
Prenatal Exposures to Environmental Chemicals and Children's Neurodevelopment: An Update
por: Bellinger, David C
Publicado: (2013)